Results 231 to 240 of about 45,745 (258)

The therapeutic use of antibodies for malignancy

Transfusion Clinique et Biologique, 2001
The idea of using the specificity of antibodies to target malignant cells was put forward very soon after the discovery of techniques to generate monoclonal reagents. The responses seen with mouse anti-idiotype in patients with B-cell lymphomas indicated the potential of this approach, but it was some years before key technical obstacles were overcome ...
openaire   +3 more sources

Antibody-based therapeutics

Drug Metabolism and Pharmacokinetics, 2019
Tatsuhiko, Tachibana, Takashi, Kuwabara
openaire   +2 more sources

Therapeutic Monoclonal Antibodies against Cancer: Present and Future

Cells, 2023
Marisa Delgado, JOSÉ A Garcia-Sanz
exaly  

Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies

International Journal of Molecular Sciences, 2022
Juan C Almagro, Gabriela Mellado-Sánchez, Sonia Mayra Perez-Tapia   +2 more
exaly  

Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress

Cell, 2021
Lauren E Williamson, Minh H Tran, Vicky Roy   +2 more
exaly  

Engineered antibody therapeutics

Advanced Drug Delivery Reviews, 2006
openaire   +2 more sources

Advances in the assessment and control of the effector functions of therapeutic antibodies

Nature Reviews Drug Discovery, 2011
An Song, Shan Chung, Anthony Mire-Sluis   +2 more
exaly  

The “less-is-more” in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity

MAbs, 2018
Kah Fai Chan, Zhiwei Song
exaly  

Therapeutic antibodies for autoimmunity and inflammation

Nature Reviews Immunology, 2010
Andrew C Chan, Paul Carter, Chan Andrew C   +2 more
exaly  

Therapeutic antibodies for human diseases at the dawn of the twenty-first century

Nature Reviews Drug Discovery, 2003
Inger Sandlie, Sandlie Inger
exaly